Results 241 to 250 of about 22,337 (268)
Some of the next articles are maybe not open access.
Pharmacological Characterization of PD151832, an M1 Muscarinic Receptor Agonist
1997Alzheimer’s disease (AD) is an age-related disorder characterized by progressive neurological impairment. Among neurotransmitters affected, the loss of forebrain cholinergic neurons has been well documented with the results contributing to the idea that therapies based on cholinergic pharmacology would be useful treatments in AD (Bartus et al., 1982 ...
Haile Tecle +11 more
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
A role for the M1 muscarinic receptor in gastrointestinal motility
Journal of Pharmacological and Toxicological Methods, 2019Stephen Jenkinson +5 more
openaire +2 more sources
Central muscarinic analgesia is mediated by M1 receptors
European Journal of Pharmacology, 1990L. Fantetti +5 more
openaire +2 more sources
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Evidence of muscarinic M1 receptors on human airways
Pharmacological Research Communications, 1988V. Guarino +6 more
openaire +2 more sources